vs

Side-by-side financial comparison of Star Equity Holdings, Inc. (STRR) and Vericel Corp (VCEL). Click either name above to swap in a different company.

Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $56.8M, roughly 1.6× Star Equity Holdings, Inc.). Vericel Corp runs the higher net margin — 25.0% vs -3.0%, a 28.0% gap on every dollar of revenue. On growth, Star Equity Holdings, Inc. posted the faster year-over-year revenue change (69.0% vs 23.3%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $-9.0M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 29.5%).

Artists Equity is an American production company founded by actors and filmmakers Ben Affleck and Matt Damon in November 2022.

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

STRR vs VCEL — Head-to-Head

Bigger by revenue
VCEL
VCEL
1.6× larger
VCEL
$92.9M
$56.8M
STRR
Growing faster (revenue YoY)
STRR
STRR
+45.8% gap
STRR
69.0%
23.3%
VCEL
Higher net margin
VCEL
VCEL
28.0% more per $
VCEL
25.0%
-3.0%
STRR
More free cash flow
VCEL
VCEL
$21.8M more FCF
VCEL
$12.8M
$-9.0M
STRR
Faster 2-yr revenue CAGR
VCEL
VCEL
Annualised
VCEL
34.6%
29.5%
STRR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
STRR
STRR
VCEL
VCEL
Revenue
$56.8M
$92.9M
Net Profit
$-1.7M
$23.2M
Gross Margin
78.7%
Operating Margin
-0.2%
24.1%
Net Margin
-3.0%
25.0%
Revenue YoY
69.0%
23.3%
Net Profit YoY
-192.1%
17.3%
EPS (diluted)
$-0.49
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STRR
STRR
VCEL
VCEL
Q4 25
$56.8M
$92.9M
Q3 25
$48.0M
$67.5M
Q2 25
$35.5M
$63.2M
Q1 25
$31.9M
$52.6M
Q4 24
$33.6M
$75.4M
Q3 24
$36.9M
$57.9M
Q2 24
$35.7M
$52.7M
Q1 24
$33.9M
$51.3M
Net Profit
STRR
STRR
VCEL
VCEL
Q4 25
$-1.7M
$23.2M
Q3 25
$-1.8M
$5.1M
Q2 25
$-688.0K
$-553.0K
Q1 25
$-1.8M
$-11.2M
Q4 24
$-585.0K
$19.8M
Q3 24
$-846.0K
$-901.0K
Q2 24
$-441.0K
$-4.7M
Q1 24
$-2.9M
$-3.9M
Gross Margin
STRR
STRR
VCEL
VCEL
Q4 25
78.7%
Q3 25
43.0%
73.5%
Q2 25
73.7%
Q1 25
69.0%
Q4 24
77.6%
Q3 24
50.5%
71.9%
Q2 24
69.5%
Q1 24
68.9%
Operating Margin
STRR
STRR
VCEL
VCEL
Q4 25
-0.2%
24.1%
Q3 25
-3.4%
5.1%
Q2 25
-0.6%
-3.2%
Q1 25
-5.4%
-24.3%
Q4 24
-0.4%
24.5%
Q3 24
-1.2%
-4.3%
Q2 24
-0.5%
-11.5%
Q1 24
-9.0%
-10.7%
Net Margin
STRR
STRR
VCEL
VCEL
Q4 25
-3.0%
25.0%
Q3 25
-3.7%
7.5%
Q2 25
-1.9%
-0.9%
Q1 25
-5.5%
-21.4%
Q4 24
-1.7%
26.3%
Q3 24
-2.3%
-1.6%
Q2 24
-1.2%
-8.9%
Q1 24
-8.6%
-7.5%
EPS (diluted)
STRR
STRR
VCEL
VCEL
Q4 25
$-0.49
$0.46
Q3 25
$-0.54
$0.10
Q2 25
$-0.23
$-0.01
Q1 25
$-0.59
$-0.23
Q4 24
$-0.21
$0.40
Q3 24
$-0.28
$-0.02
Q2 24
$-0.15
$-0.10
Q1 24
$-0.95
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STRR
STRR
VCEL
VCEL
Cash + ST InvestmentsLiquidity on hand
$10.3M
$137.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$65.7M
$354.6M
Total Assets
$113.2M
$488.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STRR
STRR
VCEL
VCEL
Q4 25
$10.3M
$137.5M
Q3 25
$15.4M
$135.4M
Q2 25
$16.8M
$116.9M
Q1 25
$16.6M
$112.9M
Q4 24
$17.0M
$116.2M
Q3 24
$15.8M
$101.7M
Q2 24
$14.7M
$102.5M
Q1 24
$20.4M
$110.6M
Total Debt
STRR
STRR
VCEL
VCEL
Q4 25
Q3 25
$6.5M
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
STRR
STRR
VCEL
VCEL
Q4 25
$65.7M
$354.6M
Q3 25
$67.8M
$321.9M
Q2 25
$40.1M
$306.8M
Q1 25
$39.5M
$295.5M
Q4 24
$40.4M
$292.0M
Q3 24
$42.9M
$257.5M
Q2 24
$42.6M
$243.0M
Q1 24
$44.3M
$233.9M
Total Assets
STRR
STRR
VCEL
VCEL
Q4 25
$113.2M
$488.0M
Q3 25
$117.1M
$453.3M
Q2 25
$55.6M
$435.6M
Q1 25
$53.2M
$424.6M
Q4 24
$52.6M
$432.7M
Q3 24
$52.6M
$390.4M
Q2 24
$52.6M
$376.8M
Q1 24
$52.6M
$356.7M
Debt / Equity
STRR
STRR
VCEL
VCEL
Q4 25
Q3 25
0.10×
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STRR
STRR
VCEL
VCEL
Operating Cash FlowLast quarter
$-7.3M
$15.0M
Free Cash FlowOCF − Capex
$-9.0M
$12.8M
FCF MarginFCF / Revenue
-15.8%
13.8%
Capex IntensityCapex / Revenue
3.0%
2.4%
Cash ConversionOCF / Net Profit
0.65×
TTM Free Cash FlowTrailing 4 quarters
$-13.0M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STRR
STRR
VCEL
VCEL
Q4 25
$-7.3M
$15.0M
Q3 25
$-2.7M
$22.1M
Q2 25
$139.0K
$8.2M
Q1 25
$-802.0K
$6.6M
Q4 24
$-2.8M
$22.2M
Q3 24
$1.3M
$10.2M
Q2 24
$-4.3M
$18.5M
Q1 24
$-1.8M
$7.2M
Free Cash Flow
STRR
STRR
VCEL
VCEL
Q4 25
$-9.0M
$12.8M
Q3 25
$-3.4M
$19.5M
Q2 25
$102.0K
$81.0K
Q1 25
$-808.0K
$-7.6M
Q4 24
$-2.8M
$8.5M
Q3 24
$1.3M
$-9.2M
Q2 24
$-4.3M
$1.8M
Q1 24
$-1.8M
$-6.8M
FCF Margin
STRR
STRR
VCEL
VCEL
Q4 25
-15.8%
13.8%
Q3 25
-7.0%
28.8%
Q2 25
0.3%
0.1%
Q1 25
-2.5%
-14.5%
Q4 24
-8.3%
11.2%
Q3 24
3.4%
-15.9%
Q2 24
-12.0%
3.4%
Q1 24
-5.3%
-13.3%
Capex Intensity
STRR
STRR
VCEL
VCEL
Q4 25
3.0%
2.4%
Q3 25
1.3%
3.9%
Q2 25
0.1%
12.9%
Q1 25
0.0%
27.0%
Q4 24
0.1%
18.3%
Q3 24
0.0%
33.5%
Q2 24
0.0%
31.8%
Q1 24
0.0%
27.3%
Cash Conversion
STRR
STRR
VCEL
VCEL
Q4 25
0.65×
Q3 25
4.35×
Q2 25
Q1 25
Q4 24
1.12×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STRR
STRR

Revenue From Other Contracts With Customers$27.6M49%
Other$24.3M43%
Energy Services Segment$4.9M9%

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

Related Comparisons